Literature DB >> 15686937

Uric acid may inhibit glucose-induced insulin secretion via binding to an essential arginine residue in rat pancreatic beta-cells.

Boris Rocić1, Marijana Vucić-Lovrencić, Nevenka Poje, Mirko Poje, Federico Bertuzzi.   

Abstract

Uric acid (1a) suppresses basal insulin release in isolated rat pancreatic islets and inhibition of glucose-stimulated insulin secretion (GSIS) occurs right at hyperuricaemic levels (0.4 mM). Conversely, 1 mM guanidinium urate (2a) was completely ineffective, strongly suggesting that binding to an essential arginine residue triggers the inhibitory effect. A specific recognition of 1a molecule at the crucial beta-cell receptor is probably involved in the blocking glucose signal transduction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15686937     DOI: 10.1016/j.bmcl.2004.12.003

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Is lower uric acid level better? A combined cross-sectional and longitudinal study in the elderly.

Authors:  Chang-Hsun Hsieh; Jiunn-Diann Lin; Chung-Ze Wu; Chun-Hsien Hsu; Dee Pei; Yao-Jen Liang; Yen-Lin Chen
Journal:  Endocrine       Date:  2014-02-21       Impact factor: 3.633

2.  Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis.

Authors:  Han-Gyul Yoo; Sang-Il Lee; Han-Jung Chae; Seoung Ju Park; Yong Chul Lee; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2009-12-20       Impact factor: 2.631

3.  Serum uric acid levels are associated with homeostasis model assessment in obese nondiabetic patients: HOMA and uric acid.

Authors:  Cesar I Elizalde-Barrera; Teresa Estrada-García; Jose J Lozano-Nuevo; Ana K Garro-Almendaro; Catalina López-Saucedo; Alberto F Rubio-Guerra
Journal:  Ther Adv Endocrinol Metab       Date:  2017-10-11       Impact factor: 3.565

4.  Preserved C-peptide secretion in patients with type 1 diabetes and incipient chronic complications is associated with lower serum resistin and higher uric acid levels.

Authors:  Tomislav Bulum; Martina Tomić; Sandra Vučković-Rebrina; Vinko Roso; Marijana Vučić Lovrenčić; Lea Duvnjak
Journal:  J Diabetes Metab Disord       Date:  2020-08-29

5.  Relationship between Serum Concentration of Uric Acid and Insulin Secretion among Adults with Type 2 Diabetes Mellitus.

Authors:  J A Robles-Cervantes; M G Ramos-Zavala; M González-Ortiz; E Martínez-Abundis; C Valencia-Sandoval; A Torres-Chávez; C Espinel-Bermúdez; N J Santiago-Hernández; S O Hernández-González
Journal:  Int J Endocrinol       Date:  2011-12-14       Impact factor: 3.257

6.  The association between elevated serum uric acid levels and islet β-cell function indexes in newly diagnosed type 2 diabetes mellitus: a cross-sectional study.

Authors:  Yimeng Hu; Jie Liu; Huiqiong Li; Hui Zhu; Linjie Liu; Yin Yuan; Jing Chen; Ye Wang; Xuemei Hu; Yancheng Xu
Journal:  PeerJ       Date:  2018-03-09       Impact factor: 2.984

Review 7.  Uric acid-induced pancreatic β-cell dysfunction.

Authors:  Asghar Ghasemi
Journal:  BMC Endocr Disord       Date:  2021-02-16       Impact factor: 2.763

8.  DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1.

Authors:  Genaro A Paredes-Juarez; Neha M Sahasrabudhe; Reina S Tjoelker; Bart J de Haan; Marten A Engelse; Eelco J P de Koning; Marijke M Faas; Paul de Vos
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

9.  Direct and Indirect Effects of Serum Uric Acid on Blood Sugar Levels in Patients with Prediabetes: A Mediation Analysis.

Authors:  Thunyarat Anothaisintawee; Dumrongrat Lertrattananon; Sangsulee Thamakaison; Sirimon Reutrakul; Boonsong Ongphiphadhanakul; Ammarin Thakkinstian
Journal:  J Diabetes Res       Date:  2017-10-29       Impact factor: 4.011

10.  Protective Effects of Astragaloside IV on Uric Acid-Induced Pancreatic β-Cell Injury through PI3K/AKT Pathway Activation.

Authors:  Zhenhuan Jiang; Gang Wang; Lingling Meng; Yunzhao Tang; Min Yang; Changlin Ni
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-10       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.